Medicare finally covers residential addiction treatment for seniors—with a catch.

What it does

This bill expands Medicare coverage to include residential substance use disorder treatment services for seniors, establishing three tiers of care (clinically managed low-intensity, clinically managed high-intensity, and medically managed) with defined facility standards, clinical requirements, and a per-diem payment system beginning October 1, 2026. Medicare will pay for bed, board, clinical services, medications, and support services at these facilities, with payment rates initially set to cover 100% of reasonable costs and adjusted annually by market-basket inflation.

Why we flagged it

The bill's core function is to add a new category of covered services under Medicare Part A—residential substance use disorder treatment—with defined facility types, clinical standards, and a prospective payment system. This is straightforward healthcare coverage expansion, not a hidden mechanism or rider.

What the text implies

• The bill delegates clinical standard-setting to 'a nonprofit medical association generally recognized for its expertise in addiction treatment' without naming the organization, creating potential regulatory capture if a single association dominates standard-setting and certification.
• Payment rates are set at 100% of 'reasonable costs' in year one, with no explicit cost-control mechanism beyond market-basket inflation in subsequent years; if facilities inflate baseline costs, the inflation adjustment perpetuates overpayment.

The full analysis lists 5 implications of this text.

Who stands to gain

residential substance use disorder treatment facilities (private and nonprofit operators); addiction medicine providers and clinicians; pharmaceutical companies (increased demand for addiction medications, particularly buprenorphine and